TY - JOUR
T1 - Surgical rescue after transcatheter interventional procedures in congenital heart disease patients
T2 - An existing problem
AU - Varrica, Alessandro
AU - Rito, Mauro Lo
AU - Generali, Tommaso
AU - Satriano, Angela
AU - D'Oria, Veronica
AU - Conforti, Erica
AU - Pluchinotta, Francesca
AU - Chessa, Massimo
AU - Butera, Gianfranco
AU - Frigiola, Alessandro
AU - Carminati, Mario
AU - Giamberti, Alessandro
PY - 2017/2/1
Y1 - 2017/2/1
N2 - Aims: Nowadays, transcatheter approaches are the treatment of choice for several congenital heart defects. However, adverse events may occur during interventional procedures. Even if the complication rate has been reduced remarkably because of learning curve and technological improvements, catastrophic events are still possible. The aim of this study was to review cardiac catheter complications that required surgical treatment during or after a percutaneous procedure. Methods and results: We evaluated retrospectively a thirteen-year experience at our centre. We examined all transcatheter procedures involving device release or implantation needing surgical rescue. We performed 3,205 interventional catheterisation procedures with device release or implantation: ASD device closure (n=2,205), PDA device occlusion (n=355), VSD device closure (n=218), aortic coarctation or recoarctation stenting (n=199), pulmonary artery stenting (n=154) and pulmonary valve implantation (n=74). Complications that required surgical treatment occurred in 1.2% of cases. Early surgery was performed in 22 cases, while in 18 patients a surgical treatment related to late complications was performed in a mean follow-up of 17 months. There were no deaths in either group. Conclusions: A spectrum of CHD can be treated today by transcatheter interventional procedures with good results and a low, but not negligible, risk of complications that require a surgical operation. The risk of developing late complications makes a long-term follow-up mandatory in such patients.
AB - Aims: Nowadays, transcatheter approaches are the treatment of choice for several congenital heart defects. However, adverse events may occur during interventional procedures. Even if the complication rate has been reduced remarkably because of learning curve and technological improvements, catastrophic events are still possible. The aim of this study was to review cardiac catheter complications that required surgical treatment during or after a percutaneous procedure. Methods and results: We evaluated retrospectively a thirteen-year experience at our centre. We examined all transcatheter procedures involving device release or implantation needing surgical rescue. We performed 3,205 interventional catheterisation procedures with device release or implantation: ASD device closure (n=2,205), PDA device occlusion (n=355), VSD device closure (n=218), aortic coarctation or recoarctation stenting (n=199), pulmonary artery stenting (n=154) and pulmonary valve implantation (n=74). Complications that required surgical treatment occurred in 1.2% of cases. Early surgery was performed in 22 cases, while in 18 patients a surgical treatment related to late complications was performed in a mean follow-up of 17 months. There were no deaths in either group. Conclusions: A spectrum of CHD can be treated today by transcatheter interventional procedures with good results and a low, but not negligible, risk of complications that require a surgical operation. The risk of developing late complications makes a long-term follow-up mandatory in such patients.
KW - ASD closure
KW - Device release
KW - Surgical rescue
UR - http://www.scopus.com/inward/record.url?scp=85015989890&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85015989890&partnerID=8YFLogxK
U2 - 10.4244/EIJ-D-16-00031
DO - 10.4244/EIJ-D-16-00031
M3 - Article
C2 - 27773863
AN - SCOPUS:85015989890
SN - 1774-024X
VL - 12
SP - 1724
EP - 1729
JO - EuroIntervention
JF - EuroIntervention
IS - 14
ER -